Purchase Order 75F40119P10112

Award Date 3/14/19
Potential Completion Date 3/24/24
Potential Value $91K
Ultimate Awardee
Waters Corporation
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20903, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Food and Drug Administration (FDA) to Waters Technologies Corporation, a subsidiary of Waters Corporation, for the upgrade of Waters HPLC-PDA (high-performance liquid chromatography-photodiode array) systems. The contract has a ceiling value of $50,727.24 and was awarded on April 14, 2017, with a completion date of April 13, 2018. The contract was not set aside for any specific business designation. Waters Corporation and its...
This federal contract award to Waters Technologies Corporation, doing business as Waters, is a Firm Fixed Price Delivery Order under the Multiple Award Schedule (MAS) contract. The $112,347.24 contract is for a HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) SYSTEM SERVICE CONTRACT with the Food and Drug Administration (FDA), a civilian agency. The contract has an ultimate completion date of March 24, 2029. Waters Technologies is a leading provider of laboratory equipment, software, services,...
This is a federal contract award from the Food and Drug Administration (FDA) to Waters Technologies Corporation, a subsidiary of Waters Corporation, for an ultra-high performance liquid chromatography (UPLC) system. The $80,743.03 firm fixed-price delivery order does not have a set-aside designation, indicating Waters Technologies Corporation competed for the contract on a full and open basis. Waters Corporation and its subsidiaries are leading manufacturers of advanced scientific...
This is a firm fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Waters Technologies Corporation, doing business as Waters, for an ultra high performance liquid chromatography (UHPLC) mass spectrometer system with post-warranty service and maintenance. The $172,478.26 contract is funded through the FDA's Scientific Equipment and Services Multiple Award Schedule contract, with a period of performance ending on January 12, 2021. This award has no set-aside...
This is a federal contract award made by the Food and Drug Administration (FDA) to Waters Technologies Corporation, a manufacturer of laboratory equipment, software, and services. The contract, valued at $241,342.60, is for the purchase of a Liquid Chromatography-Mass Spectrometry (LCMS) system and related services. The contract is a Firm Fixed Price Purchase Order with no set-aside designation. Waters Technologies is a well-established provider of analytical instruments and related products...
This federal contract award, valued at $53,800.51, was issued by the Food and Drug Administration (FDA) to Waters Technologies Corporation, a subsidiary of Waters Corporation. The contract is for the delivery of an ultra-high pressure liquid chromatography (UHPLC) system compatible with a Q Exactive HF spectrometer and Xcalibur 3.0.63 software package. This is a firm fixed price delivery order awarded under the General Services Administration's (GSA) Multiple Award Schedule (MAS) contract for...
This is a federal contract award to Waters Technologies Corporation, a leading provider of analytical instrumentation and laboratory equipment, for the delivery of an ultra-high performance liquid chromatography (UHPLC) system. The contract, with a ceiling value of $495,091.68, was awarded by the Food and Drug Administration (FDA), a civilian agency, on a firm fixed price basis. The contract is a delivery order issued against Waters' existing GSA Multiple Award Schedule (MAS) contract for...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a Firm Fixed Price Delivery Order contract for an UHPLC (Ultra High-Performance Liquid Chromatography) System to the prime contractor Waters Technologies Corporation (doing business as Waters) on September 17, 2018. The contract has a potential value of $188,823.71 and a completion date of March 9, 2023. The contract was awarded under the General Services Administration (GSA) Multiple Award Schedule...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a firm fixed price delivery order to Waters Technologies Corporation, doing business as Waters, for the provision of a high performance liquid chromatograph (HPLC/UHPLC) quaternary pump with a photodiode array detector (PDA). The $158,848.10 contract was awarded on September 20, 2019 and has a completion date of September 25, 2020. This requirement was not set aside for a specific small business...
The Department of Health and Human Services Food and Drug Administration awarded a $171,419.98 firm fixed price delivery order to Waters Technologies Corporation, doing business as Waters, under its Multiple Award Schedule contract with the General Services Administration. The order is for one ultra high-performance chromatography system to support the FDA's analytical testing programs. Waters Corporation is the parent company of Waters Technologies. Performance will take place in Berwyn...

This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Waters Technologies Corporation, a subsidiary of Waters Corporation, for the provision of two Waters HPLC (High-Performance Liquid Chromatography) systems. The contract, valued at $90,508.58, has an ultimate completion date of March 24, 2024. This award is not associated with a set-aside program. Waters Technologies Corporation is a leading manufacturer of sophisticated scientific instruments, software, and services, primarily focused on liquid chromatography, mass spectrometry, and thermal analysis technologies. The company has been awarded numerous prime federal contracts across various agencies to supply advanced analytical solutions, including liquid chromatography systems, mass spectrometers, and associated services. This contract aligns with the FDA's mission to ensure the safety and efficacy of the products it regulates, as HPLC systems are critical tools for pharmaceutical and medical device analysis and testing.

Generated 6/29/25, 1:30 AM